Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Laryngeal cryptococcosis: Literature review and guidelines for laser ablation of fungal lesions
Jeng, Jack Y., Tomblinson, Courtney M. , Ocal, Idris Tolgay, Vikram, Holenarasipur R. , Vikram, Holenarasipur R. , Lott, David G.

The Laryngoscope | November 4, 2015 | Volume: 126 | Issue: 7 | Pages: 1625-1629

10.1002/lary.25749 | PMID 26536499 Get It

Evaluation of the Perceived Association Between Resident Turnover and the Outcomes of Patients Who Undergo Emergency General Surgery
Shah, Adil A. , Zogg, Cheryl K. , Nitzschke, Stephanie , Changoor, Navin R. , Havens, Joaquim M. , Salim, Alí , Cooper, Zara , Haider, Adil H.

JAMA Surgery | November 4, 2015 | Volume: 151 | Issue: 3 | Pages: 217

10.1001/jamasurg.2015.3940 | PMID 26536282 Get It

(Z)-3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one
Hirsova, Petra , Doležel, Jan, Kučerová-Chlupáčová, Marta , Kuneš, Jiřı́ , Pilařová, Veronika , Nováková, Lucie , Hirsova, Petra , Opletalová, Veronika

Molbank | November 4, 2015 | Volume: 2015 | Issue: 4 | Pages: M872

10.3390/m872 Get It

3-Aminorhodanine reacts with aldehydes to form either 5-[(aryl)alkylidene]-substituted products or Schiff bases or derivatives substituted at both the 3-amino group and the 5-methylene group, depending on the reaction conditions. In this note, synthesis and characterization of 3-amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one is reported.
Disease homogeneity and treatment heterogeneity in idiopathic subglottic stenosis
Gelbard, Alexander , Donovan, Donald T., Ongkasuwan, Julina , Nouraei, S.A.R. , Sandhu, Guri, Benninger, Michael S. , Bryson, Paul C. , Lorenz, Robert R. , Gadkaree, Shekhar K. , Edell, Eric S. , Ekbom, Dale C. , Kasperbauer, Jan L. , Maldonado, Fabien , Schindler, Joshua S. , Smith, Marshall E. , Daniero, James J. , Garrett, C. Gaelyn , Netterville, James L. , Rickman, Otis B. , Sinard, Robert J. , Wootten, Christopher T. , Francis, David O. , Tierney, William S. , Hillel, Alexander T. , Lott, David G. , Ongkasuwan, Julian , Gelbard, Alexander

The Laryngoscope | November 4, 2015 | Volume: 126 | Issue: 6 | Pages: 1390-1396

10.1002/lary.25708 | PMID 26536285 Get It

Objectives/Hypothesis Idiopathic subglottic stenosis (iSGS) is a rare and potentially life‐threatening disease marked by recurrent and progressive airway obstruction frequently requiring repeated surgery to stabilize the airway. Unknown etiology and low disease prevalence have limited the ability to characterize the natural history of iSGS and resulted in variability in surgical management. It is uncertain how this variation relates to clinical outcomes. Study Design Medical record abstraction. Methods Utilizing an international, multi‐institutional collaborative, we collected retrospective data on patient characteristics, treatment, and clinical outcomes. We investigated variation between and within open and endoscopic treatment approaches and assessed therapeutic outcomes; specifically, disease recurrence and need for tracheostomy at last follow‐up. Results Strikingly, 479 iSGS patients across 10 participating centers were nearly exclusively female (98%, 95% confidence interval [CI], 96.1–99.6), Caucasian (95%, 95% CI, 92.2–98.8), and otherwise healthy (mean age‐adjusted Charlson Comorbidity Index 1.5; 95% CI, 1.44–1.69). The patients presented at a mean age of 50 years (95% CI, 48.8–51.1). A total of 80.2% were managed endoscopically, whereas 19.8% underwent open reconstruction. Endoscopic surgery had a significantly higher rate of disease recurrence than the open approach (chi 2 = 4.09, P = 0.043). Tracheostomy was avoided in 97% of patients irrespective of surgical approach (95% CI, 94.5–99.8). Interestingly, there were outliers in rates of disease recurrence between centers using similar treatment approaches. Conclusion Idiopathic subglottic stenosis patients are surprisingly homogeneous. The heterogeneity of treatment approaches and the observed outliers in disease recurrence rates between centers raises the potential for improved clinical outcomes through a detailed understanding of the processes of care. Level of Evidence 4. Laryngoscope , 126:1390–1396, 2016
Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States
Deshmukh, Abhishek , Patel, Nileshkumar , Patel, Nileshkumar, Patel, Achint , Patel, Nilay, Patel, Nilay, Arora, Shilpkumar , Noheria, Amit , Mulpuru, Siva K. , Badheka, Apurva, Fischer, Avi, Coffey, James O., Cha, Yong‐Mei , Friedman, Paul A. , Asirvatham, Samuel J. , Viles-González, Juan F., Patel, Achint A, Kapa, Suraj , Mulpuru, Siva, Patel, Nileshkumar, Noseworthy, Peter A. , Patel, Nilay, Patel, Nilay, Asirvatham, Samuel J

Circulation | November 4, 2015 | Volume: 132 | Issue: 25 | Pages: 2363-2371

10.1161/circulationaha.114.013801 | PMID 26534954 Get It

Background— Transvenous lead removal (TLR) has made significant progress with respect to innovation, efficacy, and safety. However, limited data exist regarding trends in use and adverse outcomes outside the centers of considerable experience for TLR. The aim of our study was to examine use patterns, frequency of adverse events, and influence of hospital volume on complications. Methods and Results— Using the Nationwide Inpatient Sample, we identified 91 890 TLR procedures. We investigated common complications including pericardial complications (hemopericardium, cardiac tamponade, or pericardiocentesis), pneumothorax, stroke, vascular complications (consisting of hemorrhage/hematoma, incidents requiring surgical repair, and accidental arterial puncture), and in-hospital deaths described with TLR, defining them by the validated International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code. We specifically assessed in-hospital death (2.2%), hemorrhage requiring transfusion (2.6%), vascular complications (2.0%), pericardial complications (1.4%), open heart surgery (0.2%), and postoperative respiratory failure (2.4%). Independent predictors of complications were female sex and device infections. Hospital volume was not independently associated with higher complications. There was a significant rise in overall complication rates over the study period. Conclusions— The overall complication rate in patients undergoing TLR was higher than previously reported. Female sex and device infections are associated with higher complications. Hospital volume was not associated with higher complication rates. The number of adverse events in the literature likely underestimates the actual number of complications associated with TLR.
Genetic loci associated with nonobstructive coronary artery disease in Caucasian women
Weng, Liming, Chen, Yii-Der Ida , Kelsey, Sheryl F., Merz, C. Noel Bairey , Pepine, Carl J. , Miller, Virginia M. , Rotter, Jerome I. , Gulati, Martha , Goodarzi, Mark O. , Taylor, Kent D. , Sopko, George S. , Cooper‐DeHoff, Rhonda M. , Bairey Merz, C Noel , Rotter, Jerome I

Physiological Genomics | November 4, 2015 | Volume: 48 | Issue: 1 | Pages: 12-20

10.1152/physiolgenomics.00067.2015 | PMID 26534935 Get It

Nonobstructive coronary artery disease (CAD) in women is associated with adverse cardiovascular (CV) outcomes; however, information regarding genetic variants that predispose women to nonobstructive CAD is lacking. Women from the Women's Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) Study were genotyped with the Cardio-MetaboChip. WISE enrolled women with symptoms and signs of ischemia referred for coronary angiography; WTH enrolled asymptomatic, community-based women without heart disease. Analyses were conducted with a case (WISE) - control (WTH) design and multivariate logistic regression models to investigate genetic variation associated with likelihood of nonobstructive CAD. One genetic marker, single nucleotide polymorphism (SNP) rs2301753 on chromosome 6 in RNF39, achieved chip-wide significance for nonobstructive CAD ( P < 9.5 × 10−7). After adjusting for baseline characteristics, we found no variants achieved chip-wide significance. However, SNP rs2301753 on chromosome 6 in RNF39 was associated with reduced likelihood of nonobstructive CAD [odds ratio (OR) 0.42 and 95% confidence interval (CI) of 0.29 to 0.68], at a nominal level of P = 5.6 × 10−6, while SNP rs12818945 in the ATP2B1 locus on chromosome 12 was associated with increased odds for nonobstructive CAD (OR 2.38 and 95% CI of 1.63 to 3.45) and nominal P = 5.8 × 10−6. The functions of RNF39 and ATP2B1 raise the possibility that genes involved in cardio-dysfunction may contribute to nonobstructive CAD in Caucasian women and may provide insights into novel approaches for therapy and prevention. If replicated, incorporation of these genetic variants into diagnostic evaluation may identify women at high risk for nonobstructive CAD.
Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex Vivo
Aredo, Bogale, Zhong, Xin , Pulido, José S. , Wang, Shusheng , He, Yu-Guang, Huang, Xianming , Brekken, Rolf A. , Ufret-Vincenty, Rafael , Li, Tao , Zhang, Kaiyan

Investigative Opthalmology & Visual Science | November 3, 2015 | Volume: 56 | Issue: 12 | Pages: 7137

10.1167/iovs.15-17302 | PMID 26529048 Get It

CD74/DQA1 dimers predispose to the development of arthritis in humanized mice
David, Luckey, Gokhale, Ameya, Johnson, Aaron , Behrens, Marshall D., Luthra, Harvinder S., Taneja, Veena , Behrens, Marshall, Luthra, Harvinder, Jois, Seetharama D. , Taneja, Veena

Immunology | November 3, 2015 | Volume: 147 | Issue: 2 | Pages: 204-211

10.1111/imm.12551 | PMID 26524976 Get It

SummaryRheumatoid arthritis (RA) is associated with the presence of certain HLA class II genes. However, why some individuals carrying RA non‐associated alleles develop arthritis is still unexplained. The trans‐heterodimer between two RA non‐associated HLA genes can render susceptibility to develop arthritis in humanized mice, DQA1*0103/DQB1*0604, suggesting a role for DQ α chains in pathogenesis. In this study we determined the role of DQA1 in arthritis by using mice expressing DQA1*0103 and lacking endogenous class II molecules. Proximity ligation assay showed that DQA1*0103 is expressed on the cell surface as a dimer with CD74. Upon immunization with type II collagen, DQA1*0103 mice generated an antigen‐specific cellular and humoral response and developed severe arthritis. Structural modelling suggests that DQA1*0103/CD74 form a pocket with similarity to the antigen binding pocket. DQA1*0103 mice present type II collagen‐derived peptides that are not presented by an arthritis‐resistant DQA1*0103/DQB1*0601 allele, suggesting that the DQA1*0103/CD74 dimer may result in presentation of unique antigens and susceptibility to develop arthritis. The present data provide a possible explanation by which the DQA1 molecule contributes to susceptibility to develop arthritis.
Putting the baby back in the bathwater
Gandhi, Rajiv , Perruccio, Anthony V. , Haddad, F. S., Kakar, Sanjeev

The Bone & Joint Journal | November 3, 2015 | Volume: 97-B | Issue: 11 | Pages: 1456-1457

10.1302/0301-620x.97b11.36981 | PMID 26530644 Get It

Recently, several high impact randomised controlled trials have been published suggesting no greater benefit from orthopaedic surgery over conservative treatment, or limited surgical intervention. These studies can have profound effects on clinical practice, leading to the abandonment of previously widely-used operations. How do surgeons who believe these operations are beneficial over conservative treatment rationalise these findings, and justify their use with hospital administrators and health care funders who require evidence for the value and efficacy of surgical treatment? Cite this article: Bone Joint J 2015;97-B:1456–7.
Bariatric surgery does not improve outcomes in patients undergoing primary total knee arthroplasty
Martin, J. Ryan , Watts, Chad D. , Taunton, Michael J. , Taunton, Michael J , Pagnano, Mark W

The Bone & Joint Journal | November 3, 2015 | Volume: 97-B | Issue: 11 | Pages: 1501-1505

10.1302/0301-620x.97b11.36477 | PMID 26530652 Get It

Bariatric surgery has been advocated as a means of reducing body mass index (BMI) and the risks associated with total knee arthroplasty (TKA). However, this has not been proved clinically. In order to determine the impact of bariatric surgery on the outcome of TKA, we identified a cohort of 91 TKAs that were performed in patients who had undergone bariatric surgery (bariatric cohort). These were matched with two separate cohorts of patients who had not undergone bariatric surgery. One was matched 1:1 with those with a higher pre-bariatric BMI (high BMI group), and the other was matched 1:2 based on those with a lower pre-TKA BMI (low BMI group). In the bariatric group, the mean BMI before bariatric surgery was 51.1 kg/m2 (37 to 72), which improved to 37.3 kg/m2 (24 to 59) at the time of TKA. Patients in the bariatric group had a higher risk of, and worse survival free of, re-operation (hazard ratio (HR) 2.6; 95% confidence interval (CI) 1.2 to 6.2; p = 0.02) compared with the high BMI group. Furthermore, the bariatric group had a higher risk of, and worse survival free of re-operation (HR 2.4; 95% CI 1.2 to 3.3; p = 0.2) and revision (HR 2.2; 95% CI 1.1 to 6.5; p = 0.04) compared with the low BMI group. While bariatric surgery reduced the BMI in our patients, more analysis is needed before recommending bariatric surgery before TKA in obese patients. Cite this article: Bone Joint J 2015;97-B:1501–5.